ADVERSE EFFECT OF CYCLOPHOSPHAMIDE AT MODERATE DOSE IN COMBINATION WITH STANDARD DRUGS ON INTRAPERITONEALLY IMPLANTED LEWIS LUNG-CARCINOMA IN MICE

被引:4
作者
FURUSAWA, E
FURUSAWA, S
机构
关键词
D O I
10.1159/000238339
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:216 / 222
页数:7
相关论文
共 16 条
[1]  
BONADONNA G, 1976, NEW ENGL J MED, V294, P406
[2]  
BRUNNER KW, 1976, CANCER CHEMOTHER R 3, V4, P125
[3]   THERAPEUTIC ACTIVITY OF PRETAZETTINE, STANDARD DRUGS, AND THE COMBINATIONS ON INTRAPERITONEALLY IMPLANTED LEWIS LUNG-CARCINOMA IN MICE [J].
FURUSAWA, E ;
FURUSAWA, E ;
SOKUGAWA, L .
CHEMOTHERAPY, 1983, 29 (04) :294-302
[4]  
GHANTA VK, 1983, CANCER RES, V43, P1097
[5]  
GIRALDI T, 1981, CANCER RES, V41, P2524
[6]   AUGMENTATION OF SPECIFIC IMMUNE-RESPONSE AGAINST A SYNGENEIC SV40-INDUCED SARCOMA IN MICE BY DEPLETION OF SUPPRESSOR T-CELLS WITH CYCLOPHOSPHAMIDE [J].
GLASER, M .
CELLULAR IMMUNOLOGY, 1979, 48 (02) :339-345
[7]  
HAVAS HF, 1981, CANCER RES, V41, P801
[8]  
ISAKOV N, 1981, JNCI-J NATL CANCER I, V66, P919
[9]  
LOONEY WB, 1980, CANCER RES, V40, P2179
[10]  
MATHE G, 1978, CANCER CHEMOTH PHARM, V1, P65